<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li Y</submitter><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>1004-1015</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11558792</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>34(4)</volume><pubmed_abstract>The International Agency for Research on Cancer has classified the tobacco-specific nitrosamines &lt;i>N&lt;/i>'-nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) as "carcinogenic to humans" (Group 1). To exert its carcinogenicity, NNN requires metabolic activation to form reactive intermediates which alkylate DNA. Previous studies have identified cytochrome P450-catalyzed 2'-hydroxylation and 5'-hydroxylation of NNN as major metabolic pathways, with preferential activation through the 5'-hydroxylation pathway in some cultured human tissues and patas monkeys. So far, the only DNA adducts identified from NNN 5'-hydroxylation in rat tissues are 2-[2-(3-pyridyl)-&lt;i>N&lt;/i>-pyrrolidinyl]-2'-deoxyinosine (Py-Py-dI), 6-[2-(3-pyridyl)-&lt;i>N&lt;/i>-pyrrolidinyl]-2'-deoxynebular</pubmed_abstract><journal>Chemical research in toxicology</journal><pubmed_title>Investigation of 2'-Deoxyadenosine-Derived Adducts Specifically Formed in Rat Liver and Lung DNA by &amp;lt;i&amp;gt;N&amp;lt;/i&amp;gt;'-Nitrosonornicotine Metabolism.</pubmed_title><pmcid>PMC11558792</pmcid><funding_grant_id>P30 CA077598</funding_grant_id><funding_grant_id>R01 CA-81301</funding_grant_id><funding_grant_id>R37 CA081301</funding_grant_id><funding_grant_id>R01 CA081301</funding_grant_id><funding_grant_id>P30 CA-077598</funding_grant_id><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Zarth AT</pubmed_authors><pubmed_authors>Hecht SS</pubmed_authors><pubmed_authors>Upadhyaya P</pubmed_authors><pubmed_authors>Carlson ES</pubmed_authors></additional><is_claimable>false</is_claimable><name>Investigation of 2'-Deoxyadenosine-Derived Adducts Specifically Formed in Rat Liver and Lung DNA by &amp;lt;i&amp;gt;N&amp;lt;/i&amp;gt;'-Nitrosonornicotine Metabolism.</name><description>The International Agency for Research on Cancer has classified the tobacco-specific nitrosamines &lt;i>N&lt;/i>'-nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) as "carcinogenic to humans" (Group 1). To exert its carcinogenicity, NNN requires metabolic activation to form reactive intermediates which alkylate DNA. Previous studies have identified cytochrome P450-catalyzed 2'-hydroxylation and 5'-hydroxylation of NNN as major metabolic pathways, with preferential activation through the 5'-hydroxylation pathway in some cultured human tissues and patas monkeys. So far, the only DNA adducts identified from NNN 5'-hydroxylation in rat tissues are 2-[2-(3-pyridyl)-&lt;i>N&lt;/i>-pyrrolidinyl]-2'-deoxyinosine (Py-Py-dI), 6-[2-(3-pyridyl)-&lt;i>N&lt;/i>-pyrrolidinyl]-2'-deoxynebular</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2025-04-04T00:33:48.592Z</modification><creation>2025-04-04T00:33:48.592Z</creation></dates><accession>S-EPMC11558792</accession><cross_references><pubmed>33720703</pubmed><doi>10.1021/acs.chemrestox.1c00012</doi></cross_references></HashMap>